Return to Publications
February 2015
RWJBarnabas HealthRutgers Cancer Institute, along with its partner RWJBarnabas Health, offers the most advanced cancer treatment options including clinical trials and novel therapeutics such as precision medicine and immunotherapy.
Drug for Lou Gehrig's Disease Boosts Radiation Effectiveness in Melanoma Laboratory Models with Brain Metastasis



Research from Rutgers Cancer Institute of New Jersey and the Ernest Mario School of Pharmacy at Rutgers University demonstrates that a drug used to treat Lou Gehrig's disease (ALS) helps radiation be more effective when it was administered to laboratory models with melanoma that had metastasized to the brain. The work - conducted by Suzie Chen, PhD, Cancer Institute member and professor of chemical biology at the Ernest Mario School of Pharmacy and James Goydos, MD, director of the Melanoma and Soft Tissue Oncology Program at the Cancer Institute and professor of surgery at Rutgers Robert Wood Johnson Medical School - appeared in a recent issue of the journal Pigment Cell & Melanoma Research.Learn more

Research Finds Smokers Have Strong Support for Many E-Cigarette Policies



As the U.S. Food and Drug Administration is preparing to issue a final ruling on whether it will extend its tobacco regulatory authority to electronic cigarettes (e-cigarettes), researchers from Rutgers Cancer Institute of New Jersey and Rutgers School of Public Health have identified strong support for a number of e-cigarette policies among smokers. Findings included strong support for advertising restrictions and placing warning labels for potential risks on the devices.Learn more

Understanding the Latest Treatment Options in Cancer Immunotherapy



As more attention is given to tumor immunology and cancer immunotherapy, several Rutgers Cancer Institute of New Jersey faculty members are joining experts in the field to further examine the latest cancer treatment options that harness the power of the immune system. As part of a CME-certified program, clinical oncologists and others involved in treating cancer patients with immunotherapy will gain a further understanding of basic immunology principles in clinical application and discuss emerging drugs. Registration is now open.Learn more

Registration Open for 2015 4-R Radiation Symposium: From Benchside to Machine



Sponsored by the Department of Radiation Oncology at Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, Rutgers New Jersey Medical School, and the Center for Continuing and Outreach Education at Rutgers, this CME-certified live activity is designed for professionals in radiotherapy treatment and research. Participants will receive an update on current and future directions of physics research in radiation oncology and the clinical implementations of new technologies.Learn more

            Rutgers Cancer Institute of New Jersey                                          NCI logo 

Office of Communications         ·        ·        732-235-9871

                        Like us on Facebook                     Join the CINJ Mailing List